Clinical Trial Update: Melanoma Biomarker Study

View source ↗

Summary

The clinical trial update notes the biomarker study in metastatic melanoma reaching completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Metastatic Melanoma | Status: COMPLETED